DaVita Inc. (NYSE:DVA) Shares Sold by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. lessened its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 50.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,732 shares of the company's stock after selling 25,364 shares during the period. Assenagon Asset Management S.A.'s holdings in DaVita were worth $4,054,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of DVA. Blue Trust Inc. increased its stake in shares of DaVita by 58.6% during the second quarter. Blue Trust Inc. now owns 211 shares of the company's stock valued at $29,000 after buying an additional 78 shares during the period. Family Firm Inc. bought a new stake in shares of DaVita in the 2nd quarter valued at about $43,000. Versant Capital Management Inc lifted its position in shares of DaVita by 90.6% in the 2nd quarter. Versant Capital Management Inc now owns 326 shares of the company's stock worth $45,000 after purchasing an additional 155 shares during the period. Friedenthal Financial bought a new position in shares of DaVita during the second quarter valued at approximately $48,000. Finally, Point72 Hong Kong Ltd purchased a new position in DaVita during the second quarter valued at approximately $68,000. Institutional investors own 90.12% of the company's stock.

DaVita Stock Performance

DVA stock traded down $17.15 during trading on Wednesday, reaching $141.16. The company had a trading volume of 3,294,604 shares, compared to its average volume of 817,192. The company has a market cap of $11.84 billion, a price-to-earnings ratio of 15.03, a price-to-earnings-growth ratio of 0.90 and a beta of 0.87. DaVita Inc. has a twelve month low of $76.17 and a twelve month high of $168.50. The company has a debt-to-equity ratio of 9.94, a quick ratio of 1.12 and a current ratio of 1.16. The firm has a 50-day simple moving average of $158.21 and a 200-day simple moving average of $146.02.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing the consensus estimate of $2.76 by ($0.17). DaVita had a return on equity of 77.00% and a net margin of 6.86%. The company had revenue of $3.26 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the previous year, the firm posted $2.85 earnings per share. The company's quarterly revenue was up 4.6% on a year-over-year basis. As a group, sell-side analysts expect that DaVita Inc. will post 9.99 earnings per share for the current year.

Insider Buying and Selling at DaVita

In related news, COO Michael David Staffieri sold 9,539 shares of DaVita stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the completion of the sale, the chief operating officer now owns 241,945 shares of the company's stock, valued at $36,299,008.35. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, COO Michael David Staffieri sold 9,539 shares of the business's stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the completion of the transaction, the chief operating officer now directly owns 241,945 shares in the company, valued at $36,299,008.35. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Javier Rodriguez sold 32,176 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $155.93, for a total value of $5,017,203.68. Following the sale, the chief executive officer now directly owns 905,659 shares in the company, valued at $141,219,407.87. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 173,482 shares of company stock worth $27,387,069. 2.00% of the stock is currently owned by insiders.

Analyst Ratings Changes

DVA has been the topic of a number of analyst reports. Bank of America lifted their price target on DaVita from $139.00 to $145.00 and gave the company an "underperform" rating in a report on Wednesday, August 7th. UBS Group lifted their target price on DaVita from $169.00 to $175.00 and gave the company a "buy" rating in a research note on Thursday, August 8th. Truist Financial increased their price target on shares of DaVita from $165.00 to $175.00 and gave the company a "hold" rating in a research report on Monday, October 7th. Finally, TD Cowen raised their price target on shares of DaVita from $139.00 to $150.00 and gave the company a "hold" rating in a report on Wednesday, July 24th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $159.00.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.